studying the mechanism of action of epigenetic drugs, a rapidly growing class of cancer chemotherapeutics. In particular he is interested in why certain cancers are resistant to these drugs and how this resistance might be targeted to increase treatment efficacy.

John is also interested in how histone modification patterns change or are conserved through the cell cycle as the numerous protein complexes required for transcription, DNA replication and repair all bind to and move through chromatin.